Another emerging inhibitory enzyme involved in the immunometabolism pathway is IDO, which is expressed by both melanoma cells and DCs, and mediates the conversion of tryptophan into kynurenines, thus inducing the local depletion of essential amino acids and restraining the recruitment of CD8+ T-cells in favor of both Treg and MDSCs. The gene discussed is CD8A; the disease is melanoma.